Article Details

Rare disease drug startup that raised $64 million a few weeks ago now seeks $115 million IPO

Retrieved on: 2018-05-26 00:18:45

Tags for this article:

Click the tags to see associated articles and topics

Rare disease drug startup that raised $64 million a few weeks ago now seeks $115 million IPO. View article details on hiswai:

Excerpt

<div>... a transport protein, Eidos' drug aims to stabilize the protein, said Neil Kumar, a former <b>Third Rock Ventures</b> principal who is Eidos' CEO.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up